AKT1 antibody (AA 465-479)
Quick Overview for AKT1 antibody (AA 465-479) (ABIN1820856)
Target
See all AKT1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 465-479
-
Specificity
- Human Akt only when phosphorylated at serine 473. Species Crossreactivity: Mouse.
-
Purification
- Affinity purified
-
Immunogen
-
Synthetic phosphopeptide corresponding to 465-479aa from human AKT (KLH).
Type of Immunogen: Synthetic phospho-peptide
-
-
-
-
Application Notes
- Approved: ELISA (0.25 μg/mL), WB (0.25 - 1 μg/mL)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Stabilizing buffer, 50 % glycerol
-
Handling Advice
- Aliquot to avoid repeated freezing and thawing.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for 1 year.
-
-
- AKT1 (V-Akt Murine Thymoma Viral Oncogene Homolog 1 (AKT1))
-
Alternative Name
- AKT1 / AKT
-
Background
-
Name/Gene ID: AKT1
Subfamily: RAC/AKT
Family: Protein Kinase
Synonyms: AKT1, AKT, AKT-1, C-AKT, Pan-AKT, PKB alpha, PKBalpha, Proto-oncogene c-Akt, Protein kinase B, Rac protein kinase alpha, PRKBA, Protein kinase B alpha, RAC-PK-alpha, PKB, PKB-ALPHA, RAC, RAC-ALPHA -
Gene ID
- 207
-
UniProt
- P31749
-
Pathways
- PI3K-Akt Signaling, RTK Signaling, TCR Signaling, AMPK Signaling, Interferon-gamma Pathway, TLR Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Response to Water Deprivation, Regulation of Actin Filament Polymerization, Carbohydrate Homeostasis, Glycosaminoglycan Metabolic Process, Cellular Glucan Metabolic Process, Regulation of Muscle Cell Differentiation, Cell-Cell Junction Organization, Regulation of Cell Size, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Negative Regulation of intrinsic apoptotic Signaling, Thromboxane A2 Receptor Signaling, Signaling of Hepatocyte Growth Factor Receptor, Positive Regulation of fat Cell Differentiation, VEGFR1 Specific Signals, VEGF Signaling, Warburg Effect
Target
-